You are here: Introduction > Presentation
 
        PreviousNext
 
Vanguard CPV:  Presentation
 
 
Vanguard CPV
Presentation
A solution for injection, each 1ml dose containing live attenuated canine parvovirus, NL-35-D strain, low passage ≥ 107.0 CCID50.
           
 
        PreviousNext
  Date updated: 9 June 2006